• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

niko.thio@unimelb.edu.au

Credentials


Position
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-3089-0871

Mr Niko Thio

Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology

42 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
    DOI: 10.1016/j.eururo.2026.03.024
  • 2026

    Journal article

    Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.
    DOI: 10.1038/s41467-026-74076-y
  • 2026

    Journal article

    Real world outcomes of neoadjuvant immune checkpoint blockade (ICB) for resectable stage III melanoma: Pathologic response and FDG PET/CT correlates.
    DOI: 10.1200/jco.2026.44.16_suppl.9569
  • 2026

    Journal article

    Metastasis-directed therapy with or without pembrolizumab for oligometastatic clear cell renal cell carcinoma: Pooled analysis of two prospective single-arm phase II trials.
    DOI: 10.1200/JCO.2026.44.7_suppl.498
  • 2025

    Conference Proceedings

    DLBCL tumor microenvironment archetype and CD4 T cell conversion to cytotoxic cells are required for response to glofitamab
    DOI: 10.1182/blood-2025-557
  • 2025

    Conference Proceedings

    Integrative analysis of the tumour immune microenvironment of breast implant-associated anaplastic large cell lymphoma using multi-omics
    DOI: 10.1182/blood-2025-3563
  • 2025

    Journal article

    A novel switch receptor enhances CAR-T cell fitness in TGF-β-enriched solid tumors 3396
    DOI: 10.1093/jimmun/vkaf283.1207
Niko Thio

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    197 | CD4 T CELL RECRUITMENT AND DIFFERENTIATION INTO A CYTOTOXIC PHENOTYPE IS ASSOCIATED WITH THE TREATMENT OF PATIENTS WITH GLOFITAMAB TOGETHER WITH R‐CHOP OR POLA‐R‐CHP
    DOI: 10.1002/hon.70094_197
  • 2025

    Journal article

    Abstract 4065: Unveiling drivers of esophageal adenocarcinoma with CRISPR pooled screen and single-cell RNA-sequencing
    DOI: 10.1158/1538-7445.am2025-4065
  • 2025

    Journal article

    Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
    DOI: 10.1038/s41420-025-02716-1

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224